Effect of CYP2C9 polymorphisms on the pharmacokinetics of indomethacin during pregnancy

BACKGROUND AND OBJECTIVE: CYP2C9 catalyzes the biotransformation of indomethacin to its inactive metabolite O-desmethylindomethacin (DMI). The aim of this work was to determine the effect of CYP2C9 polymorphisms on indomethacin metabolism in pregnant women. METHODS: Plasma concentrations of indometh...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur J Drug Metab Pharmacokinet
Glavni autori: Shah, Mansi, Xu, Meixiang, Shah, Poonam, Wang, Xiaoming, Clark, Shannon M., Costantine, Maged, West, Holly A., Nanovskaya, Tatiana N., Ahmed, Mahmoud S., Abdel-Rahman, Sherif Z., Venkataramanan, Raman, Caritis, Steve N., Hankins, Gary D.V., Rytting, Erik
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380929/
https://ncbi.nlm.nih.gov/pubmed/30159654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-018-0505-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items